secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001493152-25-001682
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem receives OTCQB delisting notice for trading below $0.01 for 30 days; 90-day cure period until April 6, 2025
--------------------------------------------------------------------------------

- Received OTC notice on Jan 6, 2025: closing bid price below $0.01 for 30 consecutive days violates Minimum Bid Price Requirement.
- Has 90-day compliance period until April 6, 2025 to regain compliance by having bid price >= $0.01 for 10 consecutive trading days.
- Failure to regain compliance by April 6, 2025 will result in removal of common stock from OTCQB.
- Company says it will monitor bid price and consider available options to resolve deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315225001682/0001493152-25-001682-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315225001682/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001682

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer